Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Shimlas dust off Pukke before Varsity Cup semifinal
2015-03-24

Even the persistent Pukke from North-West University (NWU) fell short by losing 29-26 on Monday 23 March against the UFS Shimlas in this year’s Varsity Cup rugby tournament.

This means Shimlas have their first ever home semifinal and, for the first time, they are also the only unbeaten side in the tournament. Come Monday 30 March, the men from Kovsies will host the University of Cape Town Ikeys for the first semifinal clash of the day at 16:45 at Shimla Park on the UFS Bloemfontein Campus.

Despite the loss, Pukke did manage to secure a bonus point by scoring four tries. It was only the good kicking to the posts by Shimlas captain AJ Coertzen that made the three-point victory difference on the final score. Pukke ended fourth on the Varsity Cup log, earning them a position in the semifinal as well. The men from NWU will travel next to the University of Pretoria to face the top of the log Tuks side in the second semifinal clash.

In the Shimlas match against Pukke, UFS flank Gerhard Olivier managed to be dubbed the Player that Rocks for a second time now this season.

Shimlas point scorers against Pukke:
Tries: Elandre Huggett, Niell Jordaan, Gerhard Olivier (2)
Conversion kicks: AJ Coertzen (3)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept